PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 291,360 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 291,360 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 291,360 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $720,000 | -60.2% | 291,360 | -49.3% | 0.05% | -11.9% |
| Q3 2020 | $1,809,000 | -26.3% | 574,423 | -31.9% | 0.06% | -6.3% |
| Q2 2020 | $2,453,000 | +36.5% | 842,950 | +32.3% | 0.06% | +34.0% |
| Q1 2020 | $1,797,000 | -71.5% | 637,311 | -67.2% | 0.05% | -47.2% |
| Q4 2019 | $6,308,000 | +85.6% | 1,943,774 | +23.5% | 0.09% | +122.5% |
| Q3 2019 | $3,399,000 | -22.0% | 1,573,780 | +13.5% | 0.04% | -52.9% |
| Q2 2019 | $4,355,000 | -12.3% | 1,386,885 | +3.9% | 0.08% | -15.0% |
| Q1 2019 | $4,966,000 | – | 1,334,943 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |